Oral Delivery of Taxanes
- 1 May 2001
- journal article
- review article
- Published by Springer Nature in Investigational New Drugs
- Vol. 19 (2) , 155-162
- https://doi.org/10.1023/a:1010635000879
Abstract
Oral treatment with cytotoxic agents is tobe preferred as this administration routeis convenient to patients, reducesadministration costs and facilitates theuse of more chronic treatment regimens....Keywords
This publication has 47 references indexed in Scilit:
- A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutantsPublished by Elsevier ,2003
- Clinical pharmacology of anticancer agents in relation to formulations and administration routesCancer Treatment Reviews, 1999
- Full blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC833.Journal of Clinical Investigation, 1997
- Hypersensitivity Reactions to the Taxanes Paclitaxel and DocetaxelClinical Drug Investigation, 1997
- The Functional Role of P-Glycoprotein in the Blood–Brain BarrierJournal of Pharmaceutical Sciences, 1997
- What have we learnt thus far from mice with disrupted P-glycoprotein genes?European Journal Of Cancer, 1996
- Tissue distribution, metabolism and excretion of paclitaxel in miceAnti-Cancer Drugs, 1996
- Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugsPublished by Elsevier ,1994
- BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTERAnnual Review of Biochemistry, 1993
- Classical and novel forms of multidrug resistance and the physiological functions of P-glycoproteins in mammalsPharmacology & Therapeutics, 1993